Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy

Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy

Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by expansion of unstable CTG repeats in a non-coding region of the DMPK gene. CUG expansions in mutant DMPK transcripts sequester MBNL1 proteins in ribonuclear foci. Depletion of this protein is a primary contributor to disease s...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Cerro-Herreros, E, González-Martínez, I, Moreno, N, Espinosa-Espinosa, J, Fernández-Costa, JM, Colom-Rodrigo, A, Overby, SJ, Seoane-Miraz, D, Poyatos-García, J, Vilchez, JJ, López de Munain, A, Varela, MA, Wood, MJ, Pérez-Alonso, M, Llamusí, B, Artero, R
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Cell Press 2021

Míreanna comhchosúla

Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
de réir: Estefanía Cerro-Herreros, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy
de réir: Estefanía Cerro-Herreros, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
de réir: Overby, SJ, et al.
Foilsithe / Cruthaithe: (2022)

miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models
de réir: Estefania Cerro-Herreros, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes
de réir: Estefania Cerro-Herreros, et al.
Foilsithe / Cruthaithe: (2017-06-01)

Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
de réir: Irene González-Martínez, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Exosomal Delivery of AntagomiRs Targeting Viral and Cellular MicroRNAs Synergistically Inhibits Cancer Angiogenesis
de réir: Jianguo Wang, et al.
Foilsithe / Cruthaithe: (2020-12-01)

BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA<sup>LR</sup> Mice
de réir: Sarah J. Overby, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Delivery of AntagomiR-7 through polymer nanoparticles for assisting B Cell to alleviate systemic lupus erythematosus
de réir: Hui Guo, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells
de réir: McCully, Mark, et al.
Foilsithe / Cruthaithe: (2018)

AntagomiR-451 inhibits oxygen glucose deprivation (OGD)-induced HUVEC necrosis via activating AMPK signaling.
de réir: Xi Yang, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers.
de réir: Juan M Fernandez-Costa, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Enhanced effects of antagomiR-3074-3p-conjugated PEI-AuNPs on the odontogenic differentiation by targeting FKBP9
de réir: Tao Jiang, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Decellularized adipose matrix hydrogel-based in situ delivery of antagomiR-150-5p for rat abdominal aortic aneurysm therapy
de réir: Xin Chen, et al.
Foilsithe / Cruthaithe: (2024-12-01)

In ovo application of antagomiRs indicates a role for miR-196 in patterning the chick axial skeleton through Hox gene regulation
de réir: McGlinn, Edwina, et al.
Foilsithe / Cruthaithe: (2010)

Peptide-conjugated PMOs for the treatment of myotonic dystrophy
de réir: Stoodley, J, et al.
Foilsithe / Cruthaithe: (2022)

Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression
de réir: Maria Sabater-Arcis, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction
de réir: Mouli Chakraborty, et al.
Foilsithe / Cruthaithe: (2015-12-01)

A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1
de réir: Mikel García-Puga, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Delivery of antagomiR204-conjugated gold nanoparticles from PLGA sheets and its implication in promoting osseointegration of titanium implant in type 2 diabetes mellitus
de réir: Liu X, et al.
Foilsithe / Cruthaithe: (2017-09-01)

Use of AgomiR and AntagomiR technologies to alter satellite cell proliferation in vitro, miRNA expression, and muscle fiber hypertrophy in intrauterine growth-restricted lambs
de réir: M. A. Greene, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Targeting exosomes enveloped EBV‐miR‐BART1‐5p‐antagomiRs for NPC therapy through both anti‐vasculogenic mimicry and anti‐angiogenesis
de réir: Jianguo Wang, et al.
Foilsithe / Cruthaithe: (2023-06-01)

CNS involvement in myotonic dystrophy type 1: does sex play a role?
de réir: Joana Garmendia, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity
de réir: Judit Núñez-Manchón, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Application of antisense conjugates for the treatment of myotonic dystrophy type 1
de réir: Stoodley, J, et al.
Foilsithe / Cruthaithe: (2023)

Congenital Myotonic Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1987-09-01)

Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?
de réir: Garazi Labayru, et al.
Foilsithe / Cruthaithe: (2018-01-01)

rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences
de réir: Chantal Sellier, et al.
Foilsithe / Cruthaithe: (2018-05-01)

The myotonic dystrophies: diagnosis and management.
de réir: Turner, C, et al.
Foilsithe / Cruthaithe: (2010)

Molecular genetics of myotonic dystrophy.
de réir: Barnes, P, et al.
Foilsithe / Cruthaithe: (1993)

MRI in Congenital Myotonic Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1992-10-01)

Cerebral Hypoperfusion in Myotonic Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1993-10-01)

Myotonic dystrophy type 2
de réir: G. E. Rudenskaya, et al.
Foilsithe / Cruthaithe: (2017-02-01)

Cardiac involvement in myotonic dystrophy
de réir: Koroush Khalighi, et al.
Foilsithe / Cruthaithe: (2015-02-01)

Ophthalmological findings in myotonic dystrophy
de réir: Maddalena De Bernardo, et al.

Two enhancers control transcription of Drosophila muscleblind in the embryonic somatic musculature and in the central nervous system.
de réir: Ariadna Bargiela, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Pattern retinal dystrophy in a case of myotonic dystrophy
de réir: Chahveer Singh Bindra, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Senescence plays a role in myotonic dystrophy type 1
de réir: Mikel García-Puga, et al.
Foilsithe / Cruthaithe: (2022-10-01)

In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
de réir: Àlex L González, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
de réir: Josef Finsterer, et al.
Foilsithe / Cruthaithe: (2017-04-01)